Headquartered in Beijing, CANbridge is a privately held bio-pharmaceutical company with a mission to accelerate development and commercialization of life-changing specialty healthcare products in China and North Asia.  
        CANbridge’s strategy is to bridge world’s richest product pipeline to one of the fastest growth markets through its highly efficient commercial platform. 
          Its founder and CEO, James Xue PhD, MBA was a former Genzyme executive and founding general manager of Genzyme China.
          With its world-class management and advisory team, CANbridge has the capability to select, acquire, develop and deliver future therapeutics and diagnostics with high potential to meet seriously unmet medical needs among Chinese and Asians.            


本网站由阿里云提供云计算及安全服务 Powered by CloudDream